Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi710061, People's Republic of China.
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi710061, People's Republic of China.
Public Health Nutr. 2020 Nov;23(16):2973-2982. doi: 10.1017/S1368980019004580. Epub 2020 Apr 17.
To investigate the association of folic acid (FA) supplementation with birth weight, the risk of small for gestational age (SGA) and low birth weight (LBW) in singleton and twin pregnancy.
A population-based cross-sectional survey.
Twenty counties and ten districts in Shaanxi Province of northwestern China, 2013.
28 174 pregnant women with their infants, covering 27 818 single live births and 356 twin live births.
The prevalence of FA supplementation in singletons and twins was 63·9 and 66·3 %. The mean birth weight was 3267 (sd 459·1) g, 2525 (sd 534·0) g and 2494 (sd 539·5) g; the prevalence of SGA was 14·3, 51·4 and 53·4 %; the prevalence of LBW was 3·4, 42·4 and 46·6 % among singleton, twin A and twin B, respectively. Compared with non-users, women with FA supplementation were (β 17·3, 95 % CI 6·1, 28·4; β 166·3, 95 % CI 69·1, 263·5) associated with increased birth weight, lower risk of SGA (OR 0·85, 95 % CI 0·80, 0·92; OR 0·45, 95 % CI 0·30, 0·68) and LBW (OR 0·82, 95 % CI 0·71, 0·95; OR 0·50, 95 % CI 0·33, 0·75) in singletons and twins, and more prominent effects in twins. Moreover, there were significant interactions between FA supplementation and plurality on birth weight, SGA and LBW.
The present study suggests the association of periconceptional 0·4 mg/d FA supplementation with increased birth weight and reduced risk of SGA and LBW in both singletons and twins, and this association may be more prominent in twins.
探讨叶酸(FA)补充与单胎和双胎妊娠出生体重、小于胎龄儿(SGA)和低出生体重(LBW)风险的关系。
基于人群的横断面调查。
中国西北部陕西省的 20 个县和 10 个区,2013 年。
28174 名孕妇及其婴儿,包括 27818 例单活产儿和 356 例双活产儿。
单胎和双胎孕妇 FA 补充的流行率分别为 63.9%和 66.3%。平均出生体重分别为 3267(sd 459.1)g、2525(sd 534.0)g 和 2494(sd 539.5)g;SGA 的发生率分别为 14.3%、51.4%和 53.4%;单胎、双胎 A 和双胎 B 的 LBW 发生率分别为 3.4%、42.4%和 46.6%。与非使用者相比,FA 补充者的出生体重增加(β 17.3,95%CI 6.1,28.4;β 166.3,95%CI 69.1,263.5),SGA(OR 0.85,95%CI 0.80,0.92;OR 0.45,95%CI 0.30,0.68)和 LBW(OR 0.82,95%CI 0.71,0.95;OR 0.50,95%CI 0.33,0.75)的风险降低,且这种关联在双胎中更为显著。此外,FA 补充和多胎之间在出生体重、SGA 和 LBW 方面存在显著的交互作用。
本研究表明,围孕期补充 0.4mg/d FA 可增加单胎和双胎的出生体重,降低 SGA 和 LBW 的风险,且这种关联在双胎中更为显著。